Literature DB >> 24639346

Cutting edge: Flt3 ligand mediates STAT3-independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells.

Brian R Rosborough1, Lisa R Mathews, Benjamin M Matta, Quan Liu, Dàlia Raïch-Regué, Angus W Thomson, Hēth R Turnquist.   

Abstract

The Flt3-Flt3 ligand (Flt3L) pathway is critically involved in the differentiation and homeostasis of myeloid cells, including dendritic cells (DC); however, its role in the expansion and function of myeloid-derived suppressor cells (MDSC) has not been determined. In this article, we describe the ability of Flt3L to expand and activate murine MDSC capable of suppressing allograft rejection upon adoptive transfer. Although Flt3L expands and augments the stimulatory capacity of myeloid DC, MDSC expanded by Flt3L have increased suppressive activity. Although STAT3 is considered the central transcription factor for MDSC expansion, inhibition and genetic ablation of STAT3 did not block, but rather augmented, Flt3L-mediated MDSC expansion. MDSC suppressive function, preserved when STAT3 inhibition was removed, was reduced by genetic STAT3 deletion. Both STAT3 inhibition and deletion reduced Flt3L-mediated DC expansion, signifying that STAT3 had reciprocal effects on suppressive MDSC and immunostimulatory DC expansion. Together, these findings enhance our understanding of the immunomodulatory properties of Flt3L.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639346      PMCID: PMC3994403          DOI: 10.4049/jimmunol.1300058

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

Authors:  H J McKenna; K L Stocking; R E Miller; K Brasel; T De Smedt; E Maraskovsky; C R Maliszewski; D H Lynch; J Smith; B Pulendran; E R Roux; M Teepe; S D Lyman; J J Peschon
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

2.  IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

Authors:  Heth R Turnquist; Zhenlin Zhao; Brian R Rosborough; Quan Liu; Antonino Castellaneta; Kumiko Isse; Zhiliang Wang; Megan Lang; Donna Beer Stolz; Xin Xiao Zheng; A Jake Demetris; Foo Y Liew; Kathryn J Wood; Angus W Thomson
Journal:  J Immunol       Date:  2011-09-26       Impact factor: 5.422

3.  Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Authors:  D Mougiakakos; R Jitschin; L von Bahr; I Poschke; R Gary; B Sundberg; A Gerbitz; P Ljungman; K Le Blanc
Journal:  Leukemia       Date:  2012-07-25       Impact factor: 11.528

4.  Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.

Authors:  Saiful Anam Mir; Arunachal Chatterjee; Arkadeep Mitra; Kanchan Pathak; Sushil K Mahata; Sagartirtha Sarkar
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

5.  Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity.

Authors:  J Adolfsson; O J Borge; D Bryder; K Theilgaard-Mönch; I Astrand-Grundström; E Sitnicka; Y Sasaki; S E Jacobsen
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

6.  Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo.

Authors:  Brian R Rosborough; Antonino Castellaneta; Sudha Natarajan; Angus W Thomson; Heth R Turnquist
Journal:  J Leukoc Biol       Date:  2011-10-25       Impact factor: 4.962

7.  Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

Authors:  Steven L Highfill; Paulo C Rodriguez; Qing Zhou; Christine A Goetz; Brent H Koehn; Rachelle Veenstra; Patricia A Taylor; Angela Panoskaltsis-Mortari; Jonathan S Serody; David H Munn; Jakub Tolar; Augusto C Ochoa; Bruce R Blazar
Journal:  Blood       Date:  2010-08-31       Impact factor: 22.113

8.  Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality.

Authors:  B R Blazar; H J McKenna; A Panoskaltsis-Mortari; P A Taylor
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

Review 9.  The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.

Authors:  Je-In Youn; Dmitry I Gabrilovich
Journal:  Eur J Immunol       Date:  2010-11       Impact factor: 5.532

10.  Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.

Authors:  Jeremy D Waight; Colleen Netherby; Mary L Hensen; Austin Miller; Qiang Hu; Song Liu; Paul N Bogner; Matthew R Farren; Kelvin P Lee; Kebin Liu; Scott I Abrams
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more
  15 in total

Review 1.  Phenotype, development, and biological function of myeloid-derived suppressor cells.

Authors:  Yang Zhao; Tingting Wu; Steven Shao; Bingyi Shi; Yong Zhao
Journal:  Oncoimmunology       Date:  2015-10-14       Impact factor: 8.110

2.  In Vivo Mobilization and Functional Characterization of Nonhuman Primate Monocytic Myeloid-Derived Suppressor Cells.

Authors:  A F Zahorchak; M B Ezzelarab; L Lu; H R Turnquist; A W Thomson
Journal:  Am J Transplant       Date:  2015-09-15       Impact factor: 8.086

3.  Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells.

Authors:  Jessica Stokes; Emely A Hoffman; Megan S Molina; Jelena Eremija; Nicolas Larmonier; Yi Zeng; Emmanuel Katsanis
Journal:  Biol Blood Marrow Transplant       Date:  2018-10-13       Impact factor: 5.742

4.  AAV-Vectored Fms-Related Tyrosine Kinase 3 Ligand Inhibits CD34+ Progenitor Cell Engraftment in Humanized Mice.

Authors:  Lijun Ling; Xian Tang; Xiuyan Huang; Jingjing Li; Hui Wang; Zhiwei Chen
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-30       Impact factor: 4.147

5.  Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway.

Authors:  Kaitlin C Fogg; Will R Olson; Jamison N Miller; Aisha Khan; Carine Renner; Isaac Hale; Paul S Weisman; Pamela K Kreeger
Journal:  Cancer Lett       Date:  2019-05-24       Impact factor: 8.679

6.  Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients.

Authors:  A Schiza; J Wenthe; S Mangsbo; E Eriksson; Anders Nilsson; T H Tötterman; A Loskog; G Ullenhag
Journal:  J Transl Med       Date:  2017-04-20       Impact factor: 5.531

7.  STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

Authors:  Matthew J Reilley; Patricia McCoon; Carl Cook; Paul Lyne; Razelle Kurzrock; Youngsoo Kim; Richard Woessner; Anas Younes; John Nemunaitis; Nathan Fowler; Michael Curran; Qinying Liu; Tianyuan Zhou; Joanna Schmidt; Minji Jo; Samantha J Lee; Mason Yamashita; Steven G Hughes; Luis Fayad; Sarina Piha-Paul; Murali V P Nadella; Xiaokun Xiao; Jeff Hsu; Alexey Revenko; Brett P Monia; A Robert MacLeod; David S Hong
Journal:  J Immunother Cancer       Date:  2018-11-16       Impact factor: 13.751

Review 8.  Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets.

Authors:  Nikoleta Bizymi; Sunčica Bjelica; Astrid Olsnes Kittang; Slavko Mojsilovic; Maria Velegraki; Charalampos Pontikoglou; Mikael Roussel; Elisabeth Ersvær; Juan Francisco Santibañez; Marie Lipoldová; Helen A Papadaki
Journal:  Hemasphere       Date:  2019-01-28

Review 9.  Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy.

Authors:  Mithunah Krishnamoorthy; Lara Gerhardt; Saman Maleki Vareki
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

10.  Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death.

Authors:  Megan S Molina; Emely A Hoffman; Jessica Stokes; Nicole Kummet; Kyle A Smith; Forrest Baker; Tiffany M Zúñiga; Richard J Simpson; Emmanuel Katsanis
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.